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RCP mutations reported by Nathans et al. (1989) to
cause reduced visual acuity but with normal fundus. In
fact, figure 2 in the article by Nathans et al. (1989) shows
a fundus photograph from a patient with “progressive
bilateral central retinal degeneration” (p. 832). Other
patients are described as having macular lesions and at-
rophy, on ophthalmic examination. Therefore, a phe-
notype such as the one Bergen and Pinckers observed in
this family evidently could result from a mutation or
combination of mutations in the red- and green-pigment
genes. In these circumstances, exclusion of these genes
is essential before a new locus is assigned.
Bergen and Pinckers do indeed describe a multipoint
analysis using markers DXS8103 and DXS8069, ap-
parently spanning the RCP and GCP genes, that excludes
these genes. However, this evidence is given as “data not
shown,” no LOD scores for these markers are included
in table 3, and no reference is given to a published map
proving that these markers span the genes in question.
Furthermore, the authors’ assertion that “Southern blot
analysis with an RCP/GCP cDNA probe)did not reveal
any structural abnormalities” (Bergen and Pinckers
1997, p. 1,472) surely is insufficient, since abnormalities
at this locus can result from point mutations or from
rearrangements 4-kb upstream of the red cone–pigment
gene and 43-kb upstream of the green cone–pigment
gene. Therefore, although data excluding the RCP/GCP
locus in this family may exist, this could not be proved
on the basis of the results presented.
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Swyer Syndrome and 46,XY Partial Gonadal
Dysgenesis Associated with 9p Deletions in the
Absence of Monosomy-9p Syndrome
To the Editor:
Sex determination in humans depends on the function
of the SRY (sex-determining region, Y) gene. This gene
consists of a single exon located on the short arm of the
Y chromosome and encodes a protein that has a con-
served domain shared by the high-mobility–group nu-
clear proteins and various transcription factors (Sinclair
et al. 1990). The SRY protein has DNA-binding and
DNA-bending activities, suggesting that it may be a tran-
scription factor that controls the expression of down-
stream genes involved in sex determination and/or
differentiation (Pontiggia et al. 1994). Swyer syndrome
is characterized by a female phenotype and gonadal dys-
genesis leading to a streak gonad, in an individual with
a 46,XY chromosome complement (MIM 306100). Af-
fected individuals have normal stature and do not have
Turner stigmata (German 1970). Approximately 15%
of these cases have mutations in the SRY gene. Dupli-
cations of the locus DSS (dosage-sensitive sex reversal)
at Xp21.3 also are associated with 46,XY gonadal dys-
genesis; however, duplications of Xp are uncommon in
46,XY females (Veitia et al. 1997a). The etiology of the
majority of cases is unknown.
Partial monosomy of 9p (MIM 158170) is associated
with a syndrome characterized by mental retardation;
trigonocephaly; upward-slanting palpebral fissures;
short, broad, and webbed neck; flat nasal bridge; an-
teverted nostrils; and long philtrum (Alfi et al. 1973;
Huret et al. 1988). The presence of ambiguous genitalia
has been reported in 70% of XY individuals monosomic
for 9p (De Grouchy and Turleau 1982, pp. 162–167;
Schinzel 1984). In addition, an increasing number of
reports describe 46,XY partial or complete gonadal-dys-
genesis cases associated with deletions of 9p and pre-
senting with dysmorphic features due to either the de-
letion syndrome or the presence of a trisomic segment
(Bennett et al. 1993; Ogata et al. 1997; Veitia et al.
1997b; MIM 273350). In three of these cases, the break-
points have been defined at a molecular level, with the
smallest deleted region distal to D9S144 (Veitia et al.
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Figure 1 Detail of a hematoxylin-and-eosin–stained section of
the right gonad of patient 1. Both gonads consisted of a fibrous stroma
without primary follicles. Rare agglomerations of Leydig-like cells also
were observed. Full clinical, histological, and molecular data are avail-
able on request.
1997b) and D9S168 (Ogata et al. 1997), which map
∼21 cM from the telomere. Here, we describe the mo-
lecular analysis of two cases of 46,XY gonadal dysge-
nesis associated with deletions of 9p. One of them had
a cytogenetically detectable 9p deletion, and the other
had an apparently normal 9p.
Patient 1, of Portuguese origin, was born to unrelated
parents and presented at birth with a normal somatic
phenotype and clitoridomegalia, mild hypotonia, and a
left clubfoot. Birthweight was 2,900 g, and height was
49 cm. At age 7 years the patient had affective disorders
but a normal IQ. At age 10 years weight was 40 kg,
and height was 145 cm. At this time, internal genitalia
consisted of a normal vaginal cavity, uterus, and fallo-
pian tubes and of bilateral streak gonads. Karyotype
analysis indicated a 46,XYdel(9)(p23) chromosome
complement. Hormonal evaluation at age 9 years was
consistent with partial gonadal failure: plasma follicle-
stimulating hormone 33 mU/ml; luteinizing hormone 21
mU/ml; testosterone 46.9 ng/dl (normal 0–30 ng/dl) and,
after hCG stimulation, 68.7 ng/dl; and dihydrotestos-
terone 12 ng/dl (normal 3–10 ng/dl) and, after hCG stim-
ulation, 20 ng/dl. The gonads consisted of a fibrous
stroma without primary follicles (fig. 1). Small islands
of Leydig-like cells were observed. On the basis of the
combined endocrinology, histology, and phenotype of
the patient, the diagnosis of Swyer syndrome was made.
The analysis, by SSCP, of 4 kb around the SRY gene
failed to show the presence of mutations.
A group of 10 completely or partially 46,XY sex-
reversed patients (for whom the DNA of the parents was
available) also were analyzed, for the presence of a loss
of heterozygosity (LOH) at 9p. These cases previously
had been screened for mutations in the SRY and DSS
regions (Veitia et al. 1997a). In one case, a small deletion
was found (for details of molecular analysis, see below).
This individual, patient 2, of French origin, presented at
birth (birthweight 2,000 g, height 49 cm) with ambig-
uous external genitalia (Prader 3) and one gonad pal-
pable in the right genital fold. At laparatomy, normal
uterus, vagina, fallopian tubes, and bilateral rudimen-
tary gonads were observed. Wolffian structures such as
the epididymis were also present. Gonad histology
showed the presence of syncytial Sertolian cords and
some spermatogonia. The patient had no dysmorphic
features, and there was no evidence of psychomotor re-
tardation, except for learning difficulties and affective
disorders. High-resolution karyotype analysis indicated
an apparently normal 46,XY chromosome complement.
Final height, at age 19 years, was 163 cm. The patient
was diagnosed as having partial gonadal dysgenesis.
The breakpoints were mapped, in both cases, by anal-
ysis of the segregation of polymorphic microsatellite al-
leles. The markers used in this study were, from telomere
to centromere, D9S1779, G10023, D9S1858, VLDLR
trinucleotide repeat, D9S1813, D9S1810, D9S937,
G10183, D9S286, D9S144, D9S168, D9S256,
D9S267, and D9S254. Primer sequences for all markers
were obtained from Genome Database and Whitehead
Institute Database. The PCR reactions were performed
under standard conditions for 30 cycles, in the presence
of a fluorescently labeled dUTP derivative (R6G; Perkin
Elmer, Applied Biosystems). Analysis was performed
with an ABI370A automatic sequencer provided with
GeneScan software (ABI), according to the manufac-
turer’s instructions.
Patient 1 carried a deletion of one chromosome 9,
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Figure 2 LOH analysis of monosomy-9p sex-reversed individuals (patients 1 and 2). The loci studied for each patient are represented by
circles connected by bars representing the undeleted regions of the abnormal chromosome 9p. The positions of the sex-reversing locus and of
the region putatively associated with monosomy-9p syndrome are indicated. The molecular findings for the patients described by Ogata et al.
(1997) and Veitia et al. (1997b) also are shown, for clarity. Patients A and B (Veitia et al. 1997b) presented with complex phenotypes due to
the presence of unbalanced chromosomal segments in addition to the deletion of 9p. Notice that most breakpoints shown map between D9S286
and D9S267. This suggests that the region contained within these markers is prone to ectopic recombination. The approximate position of
SLC1A1 (WI-7925), proximal to D9S1813, is shown.
involving 9p23 (distal-middle) to pter. The rearranged
chromosome 9 was found to be of paternal origin, and
its breakpoint was located between D9S144 and
D9S267 (fig. 2). In spite of carrying a large deletion, the
patient did not present with the specific stigmata of the
monosomy-9p syndrome. The hypotonia in this and
other 9p-deleted patients could be caused by an alter-
ation of the high-affinity glutamate-transporter (exci-
tatory amino acid carrier) gene (SLC1A1), which maps
to the monosomic region (Smith et al. 1994). Mono-
somy-9p syndrome is due to the heterozygous deletion
of a critical region mapping between D9S286 and
D9S267 (Schwartz et al. 1997). However, Ogata et al.
(1997) have described a sex-reversed patient carrying a
pure 9p deletion who presented with a phenotype com-
patible with the 9p-deletion syndrome. The breakpoint
was located distal toD9S168 (20 cM from the telomere),
suggesting that the monosomy-9p critical region must
lie distal to this marker. Our results suggest that this
critical region is proximal to D9S144, because the ab-
sence of the 9p distal portion including this marker in
patient 1 is not associated with the characteristic dys-
morphology. Taken together, these data indicate that the
minimum region responsible for the syndrome may be
located between D9S144 and D9S168. Notably, both
markers have been unambiguously mapped to YAC 784-
B-4 (Whitehead Institute Database), which may contain
genes involved in brain, skeletal, and craniofacial de-
velopment. These data also indicate that the 9p dele-
tion–syndrome locus and the sex-reversal locus are dis-
tinct entities and that some 46,XY females (or even
normal individuals) without somatic anomalies may har-
bor 9p deletions. Consistent with this hypothesis, we
identified an individual (patient 2) with an apparently
normal 9p who was hemizygous for markers D9S1858
and VLDLR (fig. 2). All alleles present were of paternal
origin. The most distal heterozygous marker was
D9S1813, which maps to a point 8 cM from the telo-
mere. Since VLDLR resides in the contig WC1422, ∼2
cM telomeric with respect to D9S1813 (the distal end
of contig WC844), the breakpoint in this patient may
lie 6–8 cM from the telomere. The presence of a deletion
was confirmed by PCR amplification of somatic-cell hy-
brids containing the rearranged chromosome 9. This in-
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dividual did not present with hypotonia, and, consistent
with the hypothesis described earlier, the marker WI-
7925 (SLC1A1), mapping proximal to D9S1813
(Whitehead Institute Database), could be amplified from
the hybrids containing the deleted chromosome 9. The
molecular analysis of this patient confirmed that a de-
letion of 9p may be associated with 46,XY sex reversal
in the absence of monosomy-9p syndrome and that the
critical region for the sex-reversing locus is distal to
D9S1813. Although, given the small number of samples
studied, no statistical conclusions can be drawn from
this screening it is remarkable that 1 of 10 patients car-
ried a deletion. These deletions may be undetectable by
ordinary cytogenetic techniques, because of their very-
terminal character (Huret et al. 1988). Recently, a case
of sex reversal associated with a familial translocation
with a breakpoint at 9p24 has been described; however,
the position of the breakpoint has not been defined at
a molecular level (McDonald et al. 1997). Elsewhere,
we also have described a patient with a complex 9p
rearrangement associated with 46,XY partial gonadal
dysgenesis (Ion et al. 1998). This patient had an inverted
duplication of 9p, with a distal breakpoint proximal to
the SNF2 gene, at 9p24.1. In this case, we failed to
identify any rearrangement distal to this gene, suggesting
that the phenotype may be caused by a position effect.
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Molecular Analysis of 9p Deletions Associated with
XY Sex Reversal: Refining the Localization of a Sex-
Determining Gene to the Tip of the Chromosome
To the Editor:
Mammalian sexual development is dependent on chro-
mosomal constitution. The Y chromosome acts as a
dominant inducer of testis formation. The choice be-
tween testis and ovary equates with the choice of male
or female development (sex determination). The differ-
entiation of internal and external genitalia and second-
ary characteristics are regulated by endocrine functions
associated with the gonads (sex differentiation). Any de-
fect along the male and female pathway can result in
inconsistencies between karyotypic and phenotypic sex
(sex reversal) (Ford et al. 1959; Jacobs and Strong 1959;
Jost et al. 1973).
The molecular-genetic analysis of primary (gonadal)
sex-reversal syndromes has led to the identification of
several sex-determining genes: SRY, the only Y-linked
gene needed for testis formation; DSS, the X-linked dos-
age-sensitive sex-reversal locus; and the campomelic dys-
plasia (CD) gene SOX9. Functional studies performed
in the mouse have identified other genes involved in go-
nadogenesis, such as the Wilms tumor gene WT-1, and
the gene encoding for the steroidogenic factor 1 SF-1
(reviewed by Schafer and Goodfellow 1996). The genes
identified to date cannot account for all the sex-reversal
cases found in the literature. The reports of both familial
forms of gonadal dysgenesis and sporadic forms asso-
ciated with autosomal anomalies implicate the existence
of other loci (Schafer and Goodfellow 1996). Male-to-
female primary sex reversal has been reported in patients
with terminal deletions of the short arm of chromosome
9: unbalanced translocations and terminal deletions in
which breakpoints range from 9p21 to 9p24 (Bennett
et al. 1993; Begleiter et al. 1995; McDonald et al. 1997;
Ogata et al. 1997; Veitia et al. 1997) (MIM 273350).
The patients have normal female or ambiguous external
genitalia and varying grades of mixed gonadal dysge-
nesis, ranging from fibrous streak gonads associated
with Wolffian duct remnants to immature hypoplastic
testicles. The lack of a correlation between the size of
the deletions and the degree of impaired male devel-
opment excludes the possibility that the deletion has a
position effect on the differentiation of the sexual phe-
notype. It is likely that the interval in the 9p24 region
deleted in all patients contains gene(s) involved in the
differentiation of the male phenotype.
To better define the chromosome 9 region associated
with sex reversal, we have performed a deletion-map-
ping analysis, by looking for the loss of heterozygosity
in a panel of sex-reversed patients with translocations/
deletions of chromosome 9p. This study involves four
patients (SV, B, RB, and TO) who previously had been
reported in the literature (Hoo et al. 1989; Bennett et
al. 1993; Begleiter et al. 1995; Ogata et al. 1997) and
an additional case (GG). These individuals are mono-
somic for varying segments of the chromosome 9 short
arm. The extent of the sex reversal is variable among
them, ranging from an ambiguous intersex to a nearly
complete female phenotype. Karyotypes and clinical de-
tails are summarized in table 1.
The extent of the 9p deletions in the sex-reversed pa-
tients was analyzed by the typing of 20 microsatellite
markers localized to an interval of 27.1 cM in 9p23-
9pter. The heterozygosity of the markers tested is 170%.
Their relative order on the chromosome was derived
from an integrated map of 9p23-9pter, which combines
genetic-mapping data on the above-mentioned loci with
radiation hybrid–mapping data (fig. 1) (Bouzyk et al.
1996; Dib et al. 1996).
Loss of heterozygosity at the microsatellite loci was
scored as potential loss of one allele. For patients TO,
GG, and SV, it was possible to genotype the parents.
This allowed the ascertainment of true hemizygosity for
some of the markers tested. The results from this analysis
are summarized in table 2. The microsatellite analysis
allowed us to determine the potential maximum size of
all the deletions but did not give any information on the
minimum size of the deletions in patients RB, B, and SV.
In the case of SV, the haplotype analysis of the parents’
DNA for the potentially deleted markers was not infor-
mative. In the case of RB and B, parental DNA was not
available. To better define the breakpoints in patients
SV, RB, and B, FISH analysis also was performed, with
genomic clones from 9p24 (for details, see the legend to
fig. 1). All the results obtained from microsatellite typing
and the FISH experiments were analyzed in relation to
the integrated map of 9p23-9pter and were converted
into a map that represents the maximum deletions po-
tentially present in each patient (fig. 1, bars on right
side):
Patient GG.—The maximum deletion extends from
the telomere to D9S256-D9S269. The proximal break-
